NASDAQ:ACST
Acasti Pharma Stock News
$2.85
-0.0200 (-0.697%)
At Close: Apr 22, 2024
Acasti Pharma to Report First Quarter 2023 Financial Results on Thursday, August 11, 2022
08:15pm, Tuesday, 02'nd Aug 2022 GlobeNewswire Inc.
Call to be held on Thursday, August 11th at 1:00 PM Eastern Time
Acasti Pharma to Report First Quarter 2023 Financial Results on Thursday, August 11, 2022
04:15pm, Tuesday, 02'nd Aug 2022
Call to be held on Thursday, August 11th at 1:00 PM Eastern Time
Acasti Pharma Announces Annual Grants of Performance Stock Options
10:10pm, Wednesday, 22'nd Jun 2022 GlobeNewswire Inc.
LAVAL, Québec, June 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company with drug delivery cap
Acasti Pharma Schedules Fiscal Year 2022 Business Update Conference Call
08:15pm, Thursday, 16'th Jun 2022 GlobeNewswire Inc.
Call to be held on Tuesday, June 21st at 1:00 PM Eastern Time Call to be held on Tuesday, June 21st at 1:00 PM Eastern Time
Acasti Pharma Schedules Fiscal Year 2022 Business Update Conference Call
04:15pm, Thursday, 16'th Jun 2022
Call to be held on Tuesday, June 21st at 1:00 PM Eastern Time Call to be held on Tuesday, June 21st at 1:00 PM Eastern Time
Penny Stocks To Buy Now? 6 To Watch Under $1 This Week
01:48pm, Wednesday, 18'th May 2022 PennyStocks
Penny stocks to watch under $1 today.
The post Penny Stocks To Buy Now? 6 To Watch Under $1 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All Endpoints
11:30am, Wednesday, 18'th May 2022 GlobeNewswire Inc.
Bioavailability of IV GTX-104 compared favorably with the oral formulation of nimodipine, and no serious adverse events observed for GTX-104
Acasti Pharma's IV Hemorrhage Drug Candidate At Par With Oral Nimodipine
11:28am, Wednesday, 18'th May 2022
Acasti Pharma Inc's (NASDAQ: ACST) pharmacokinetic (PK) bridging study with IV GTX-104, its lead drug candidate for Subarachnoid Hemorrhage (SAH), met all its planned study endpoints. The study's
Penny Stocks To Buy Now? 6 To Watch Under $1 This Week
09:48am, Wednesday, 18'th May 2022
Penny stocks to watch under $1 today. The post Penny Stocks To Buy Now?
Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th
12:30pm, Monday, 25'th Apr 2022 GlobeNewswire Inc.
LAVAL, Québec, April 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Prashant Kohli, Vice President of Comme
Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th
08:30am, Monday, 25'th Apr 2022
LAVAL, Québec, April 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Prashant Kohli, Vice President of Commerc
Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors
11:30am, Friday, 25'th Mar 2022 GlobeNewswire Inc.
LAVAL, Quebec, March 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) today announces that it has appointed Michael L. Derby to its
Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan
11:30am, Tuesday, 22'nd Mar 2022 GlobeNewswire Inc.
LAVAL, Québec, March 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), announces the following patent notifications and awards rela
Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th
01:30pm, Wednesday, 09'th Mar 2022 GlobeNewswire Inc.
LAVAL, Quebec, March 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D’Alvise, President and Chief Exec
Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th
01:30pm, Wednesday, 09'th Mar 2022 GlobeNewswire
LAVAL, Quebec, March 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D’Alvise, President and Chief Executive Officer of Acasti Pharma will be presenting at the 32 nd Annual Oppenheimer Healthcare conference being held virtually March 15-17, 2022.
